Correspondence re: Y. S. Haviv, J. L. Blackwell, A. Kanerva, P. Nagi, V. Krasnykh, I. Dmitriev, M. Wang, S. Naito, X. Lei, A. Hemminki, D. Carey, and D. T. Curiel, Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors. Cancer Res., 62: 4273-4281, 2002.
Jongmans
Wim
W
Tiemessen
Dorien M
DM
Oosterwijk
Egbert
E
Mulders
Peter F A
PF
D000256:Adenoviridae / Q000145:classification / Q000235:genetics*; D002292:Carcinoma, Renal Cell / Q000235:genetics / Q000378:metabolism / Q000628:therapy* / Q000821:virology; D015316:Genetic Therapy / Q000379:methods*; D049452:Green Fluorescent Proteins; D006801:Humans; D007680:Kidney Neoplasms / Q000235:genetics / Q000378:metabolism / Q000628:therapy* / Q000821:virology; D008164:Luminescent Proteins / Q000096:biosynthesis / Q000235:genetics; D011991:Receptors, Virus / Q000378:metabolism*; D014407:Tumor Cells, Cultured
D008164:Luminescent Proteins; D011991:Receptors, Virus; C085301:adenovirus receptor; D049452:Green Fluorescent Proteins